Inactive Instrument

News Medtronic, Inc. Nyse

Equities

US5850551061

End-of-day quote Nyse Other stock markets
- ^USD	-

04:59pm	Integer Holdings to Benefit from Pulsed Field Ablation Market Growth, BofA Says	MT
Apr. 12	Penumbra, Inc. : The underdog in healthcare

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Integer Holdings to Benefit from Pulsed Field Ablation Market Growth, BofA Says	10:59am	MT
Cosmo and Medtronic unveil the future of AI in GI, Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care	10:13am	AQ
Penumbra, Inc. : The underdog in healthcare	Apr. 11
Medtronic unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care	Apr. 10	PR
Medtronic unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care	Apr. 10	AQ
Medtronic plc Announces New Advancements in Artificial Intelligence for Endoscopic Care by Unveiling ColonPRO	Apr. 10	CI
Medtronic plc Announces Collaboration with Modernizing Medicine	Apr. 10	CI
ModMed & Medtronic Collaborate to Drive Efficiencies in Documenting Colonoscopies Using AI	Apr. 10	CI
Conflicting signals on rate cuts	Apr. 09
Non-Opioid Revolution: Beacons of Hope in Opioid Crisis and a $50 Million Spin-Off	Apr. 09	AQ
ANALYST RECOMMENDATIONS : Amex, Cisco, Nasdaq, Wells Fargo, Marathon Petroleum...	Apr. 09
The Medtronic Sphere-360™ Pulse Field Ablation (PFA) catheter, a new paradigm in single-shot ablation, demonstrates impressive results in treating paroxysmal atrial fibrillation	Apr. 08	PR
Medtronic : Structural Heart Investor & Analyst Briefing	Apr. 08	PU
Transcript : Medtronic plc - Shareholder/Analyst Call	Apr. 07
SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women	Apr. 07	AQ
Medtronic plc Announces SMART Trial One-Year Data Demonstrates Medtronic Evolut? Tavr Platform as Optimal Treatment for Severe Aortic Stenosis in Patients with Small Annulus, Which Is Primarily Women	Apr. 07	CI
New survey uncovers lack of awareness around heart valve disease and risk factors among women	Apr. 07	AQ
Titan Medical Reports Fiscal Year 2023 Results	Apr. 01	MT
Medtronic Says FDA Approved Transcatheter Aortic Valve Replacement System for Heart Valve Disease	Mar. 27	MT
Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis	Mar. 27	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Medtronic plc : Still struggling to convince

November 24, 2023 at 08:21 am EST